Cathay Biotech (SHSE:688065) Tariff Resilience Score: 0/10 (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688065 Cathay Biotech Inc SHSE:688065
93 GF Score
Price ¥44.50
GF Value ¥50.18
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cathay Biotech Tariff Resilience Score?

Cathay Biotech has the Tariff Resilience Score of 0, which implies that the company might have .

Cathay Biotech has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Cathay Biotech might have .

Cathay Biotech  (SHSE:688065) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Cathay Biotech Tariff Resilience Score Related Terms

SHSE:688065
93GF Score
Cathay Biotech Inc SHSE:688065
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cathay Biotech (SHSE:688065) Overvalued in 2026?

Based on GuruFocus' analysis, Cathay Biotech stock appears to be undervalued. The current stock price of ¥44.50 is trading 11.3% below its estimated GF Value™ of ¥50.18. GuruFocus considers Cathay Biotech to be Modestly Undervalued.

Key valuation signals for SHSE:688065:

  • Tariff Resilience Score: 0
  • GF Value™: ¥50.18 vs. price of ¥44.50 (11.3% below fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688065 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cathay Biotech Business Description

Address Oasis Ring Road, Building 11, Lane 396, Minhang District, Shanghai, CHN, 201114
Cathay Biotech Inc is engaged in research, development, production, and sales of new bio-based materials. The company owns the TERRYL brand, which focuses on bio-based polyamide fibers for textiles, and ECOPENT, which serves the engineering materials market.
93GF Score

Get the complete analysis for SHSE:688065

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥44.50
Price
¥50.18
GF Value